we generated adjusted earnings per share of $num-one and strong cash flow from operations of $num-two billion.
adjusted earnings per share of $num-one represent a nearly num-two% year-over-year increase, generated by our adjusted operating income growth and lower interest expense resulting from our ongoing deleveraging efforts.
we generated adjusted earnings per share of $num-one and strong cash flow from operations of $num-two billion.
adjusted earnings per share of $num-one represent a nearly num-two% year-over-year increase, generated by our adjusted operating income growth and lower interest expense resulting from our ongoing deleveraging efforts.
given these results and our outlook, we are raising our adjusted earnings per share guidance to $num-one to $num-two.
total revenues of $num-one billion increased num-two% year over year with robust growth in all three segments.
we grew adjusted operating income by num-one%.
in fact, this year, num-one% of new covid testing customers chose to fill new prescriptions or receive a covid vaccination with cvs health.
we reported adjusted operating income of $num-one billion, a num-two% increase versus the prior year.
approximately half or $num-one billion is attributable to the contributions from the more than num-two million covid vaccines and over num-three million covid tests we administered combined with strong front store sales driven by demand for over-the-counter covid test kits and related treatment categories.